Then, the Ozempic boom happened. Madison didn’t know what to expect from Ozempic other than that it was helping people lose weight. So, in March 2023, Madison started GLP-1 medication through Claya, a ...
Research found that semaglutide, the active substance in Ozempic and the weight-loss drug Wegovy, could help curb alcohol ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...
In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...
Ozempic is a once-weekly injection used to improve blood sugar levels in patients with Type 2 diabetes. It comes in doses of 0.25, 0.5, 1 and 2 milligrams (mg). The active ingredient, semaglutide ...
Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...
A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...
SURPASS-2 was an open label, 40-week, phase-3 trial which randomized patients to receive once-weekly injections of Mounjaro at a dose of 5 mg, 10 mg, or 15 mg, or Ozempic at a dose of 1 mg.
A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback